FOLD - Amicus Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

FOLD is currently covered by 7 analysts with an average price target of $15.27. This is a potential upside of $4.84 (46.4%) from yesterday's end of day stock price of $10.43.

Amicus Therapeutics's activity chart (see below) currently has 92 price targets and 72 ratings on display. The stock rating distribution of FOLD is 41.67% HOLD and 58.33% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 57.12% with an average time for these price targets to be met of 403.43 days.

Highest price target for FOLD is $22, Lowest price target is $15, average price target is $15.27.

Most recent stock forecast was given by ANUPAM RAMA from JPMORGAN on 18-Mar-2024.

Currently out of the existing stock ratings of FOLD, 5 are a HOLD (41.67%), 7 are a BUY (58.33%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

19

$8.57 (82.17%)

19

1 months 15 days ago

6/13 (46.15%)

$7.42 (64.08%)

454

Buy

22

$11.57 (110.93%)

2 months 4 days ago

0/4 (0%)

$9.18 (71.61%)

Hold

15

$4.57 (43.82%)

14

5 months 24 days ago

2/5 (40%)

$5.02 (50.30%)

275

Buy

18

$7.57 (72.58%)

14

7 months 5 days ago

2/4 (50%)

$6.14 (51.77%)

405

Buy

16

$5.57 (53.40%)

17

1 years 9 days ago

2/6 (33.33%)

$4.51 (39.25%)

578

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is FOLD (Amicus Therapeutics) average time for price targets to be met?

On average it took 403.43 days on average for the stock forecasts to be realized with a an average price target met ratio 57.12

Which analyst has the current highest performing score on FOLD (Amicus Therapeutics) with a proven track record?

ELEMER PIROS

Which analyst has the most public recommendations on FOLD (Amicus Therapeutics)?

Elemer Piros works at BENCHMARK and has 6 price targets and 6 ratings on FOLD

Which analyst is the currently most bullish on FOLD (Amicus Therapeutics)?

Michael Ulz with highest potential upside - $14.57

Which analyst is the currently most reserved on FOLD (Amicus Therapeutics)?

Gil Blum with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?